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Background: We found that the edible green seaweed Enteromorpha linza displayed potent antimicrobial activity
against Prevotella intermedia and Porphyromonas gingivalis. To elucidate the active component of E. linza, isolation
procedures were performed.
Results: The main active compound was isolated by polarity fractionation, Sephadex LH-20 gel chromatography,
and reverse-phase high-performance liquid chromatography (RP-HPLC). The active compounds were eluted at
isocratic 95% acetonitrile by RP-HPLC and identified as unsaturated fatty acids, stearidonic acid (SA, C18:4 n-3) and
gamma-linolenic acid (GLA, C18:3 n-6) by gas chromatography–mass spectrometry, 1H nuclear magnetic resonance
(NMR) spectroscopy, and 13C NMR spectroscopy. The yields of SA and GLA from dried seaweed tissue were 6.33 ×
10-3% and 6.47 × 10-3%, respectively. The minimal inhibitory concentration values of SA and GLA were 39.06 μg/mL
against P. intermedia and 9.76 μg/mL against P. gingivalis, respectively. SA and GLA were also active against several
other oral pathogens, including Aggregatibacter actinomycetemcomitans, Candida albicans, Fusobacterium nucleatum
subsp. vincenti, and Streptococcus mutans, at micromolar concentrations.
Conclusions: These data suggest that the E. linza extracts SA and GLA are useful antimicrobial agents for the
prevention and/or treatment of periodontitis.
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Periodontitis is a chronic inflammatory disease initiated
by a group of gram-negative periodontal pathogens,
including Prevotella intermedia and Porphyromonas gin-
givalis. Systemic or topical antibiotic therapies have been
found to be useful in the treatment of periodontal dis-
ease (Slots and Ting 2002). However, antibiotics are
commonly known to induce side effects (Falagas and
Siakavellas 2000) and the development of bacterial re-
sistance (Lopez and Gerwick 1988). Thus, for many* Correspondence: ischoi@silla.ac.kr
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in any medium, provided the original work is pyears, numerous attempts have been made to develop
new agents capable of preventing and/or treating peri-
odontitis (Park et al. 2005).
Interest in marine organisms as natural sources of
pharmaceutical agents has increased recently (Newman et al.
2003). Seaweeds produce many secondary metabolites with
a variety of activities; compounds with antiviral, antifungal,
and antibacterial activity have been detected from various
marine algae (del Val et al. 2001; Newman et al. 2003).
In our previous work, we found that the edible green
seaweed Enteromorpha linza displays potent antimicro-
bial activity against P. intermedia and P. gingivalis with-
out side effects at a moderate dose (Choi et al. 2012).
Additionally, a mouth rinse containing E. linza extract
has shown clinical effects against gingivitis, as measuredOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Park et al. Botanical Studies 2013, 54:39 Page 2 of 9
http://www.as-botanicalstudies.com/content/54/1/39by the plaque index (PI), gingival index (GI), bleeding on
probing (BOP), and activity against two bacterial strains
(P. intermedia and P. gingivalis) (Cho et al. 2011). This
mouth rinse produced effects similar to those of Listerine®.
To discover therapeutic agents against periodontitis from
the seaweed with few or no side effects and potent anti-
microbial activity, we isolated and identified active anti-
microbial compounds from E. linza extract and present




The green seaweed E. linza was collected from the sea-
shore near Ildo-dong (33°31′15.06″N, 126°32′54.70″E),
Cheju Island, Korea, in April 2009. After rinsing with
tap water to remove salt and miscellanea, the samples
were dried for 1 day at room temperature using an elec-
tric fan. Samples were then ground to a powder using a
coffee grinder for 5 min and stored at −20°C until use.
Reagents
High-performance liquid chromatography (HPLC)-grade
reagents (or the highest grade available) and culture
media were purchased from Sigma Aldrich, Ltd. (Poole,
Dorset, UK). All solutions were made with ultrapure
deionized water (Milli-Q advantage A10 ultrapure water
purification system; Millipore, Billerica, MA, USA).
Isolation of antimicrobial compounds
Approximately 150 g of dried E. linza powder was
extracted with a 600-mL solution of methanol–water
(4:1) at room temperature overnight. The extract was
then filtered through Toyo No. 2 filter paper under re-
duced pressure. This extraction procedure was repeated
three times and the extracts were combined. The metha-
nol–water extract was concentrated to a dark-green resi-
due (30.2 g) under reduced pressure in an evaporator.
The extract was fractionated according to polarity, as
described by Harborne (1998). The fraction was acidified
to pH 3.0 using 2 M sulfuric acid and extracted three
times with chloroform, resulting in a moderately polar
extract that contained the main antimicrobial activity.
This fraction III (4.4 g) was loaded on a Sephadex LH-20
(Sigma LH20100; Sigma Aldrich, Ltd.) gel column (2.2 ×
100 cm) using 100% MeOH as the eluent. Each 10-mL
fraction was collected at a flow rate of 1 mL/min. The
active fraction, designated as S14 (173 mg), was dried
and dissolved in 17.3 mL MeOH for reverse-phase
high-performance liquid chromatography (RP-HPLC).
Separation of the three major peaks (S14–1, S14–2,
and S14-3) was achieved using an Alltima C18 column
(10 mm ID × 25 cm) (W. R. Grace & Co., Columbia,
MD, USA). Analysis was performed on a Waters 600gradient liquid chromatograph and a Waters 2707
autosampler (Waters Co., Milford, MA, USA) monitored
at 197 nm. The mobile phase consisted of two solvent sys-
tems: acetonitrile with 0.1% trifluoroacetic acid (TFA) and
distilled water with 0.1% TFA. Elution was performed with
an isocratic of 95% acetonitrile with 0.1% TFA (5% dis-
tilled water added) for 15 min at a flow rate of 4 mL/min.
Purification was performed using the same system to yield
the pure compound (S14-1: 8.8 mg; S14–2: 9.5 mg; S14–3:
9.7 mg). Each eluted compound was dried under a stream
of nitrogen gas.
Analytical methods
The purified compound was analyzed on a nuclear mag-
netic resonance (NMR) spectrometer (JNM-ECP 400;
JEOL, Tokyo, Japan), operating at 500 and 100 MHz for
1H and 13C, respectively, using methanol-d (CD3OD).
Gas chromatography–mass spectrometry (GC–MS) was
performed on a 5975C gas chromatograph (Agillent, Santa
Clara, CA, USA) equipped with an HP-5MS capillary co-
lumn (30 m × 250 μm× 0.25 μm). The column tempe-
rature was programmed from an initial temperature of
80°C for 2 min and raised to a final temperature of 300°C
at a rate of 5°C/min. The samples were converted to me-
thyl ester derivatives by the protocol reported by Lepage
and Roy (1986). The injection volume was 1 μL, the car-
rier gas was helium (flow rate, 1 mL/min) and the split ra-
tio was 20:1. A computerized search was performed to
identify a standard sample for comparison (Sigma 56463:
methyl stearidonate solution; Sigma L6503: methyl γ-
linolenate solution for GC) (Sukatar et al. 2006). The
structure of the purified compound was inferred by com-
parison with C18H28O2 and C18H30O2 structures from a
NMR spectra database (Aires-de-Sousa et al. 2002).
Test microorganisms and culture media
In vitro antimicrobial activity assays were performed
with the anaerobic bacteria of P. intermedia KCTC25611
and P. gingivalis KCTC381 obtained from the Korean Col-
lection for Type Culture (Deajeon, Korea). These strains
were cultivated on tryptic soy agar (Difco, Sparks, MD,
USA) media containing 10% sheep blood, 0.1% hemin
(Sigma, St. Louis, MO, USA) and vitamin K1 (Sigma,
USA) in a Bactron IV chamber (SHELLAB, Cornelius,
OR, USA) at 37°C, 5% CO2, 10% H2, and 85% N2.
Antimicrobial activity against oral pathogens
Following identification of the active compounds, their
antimicrobial activity was measured against several oral
pathogens, including anaerobic Aggregatibacter actino-
mycetemcomitans KCTC 3698, Candida albicans KCTC
17485, Fusobacterium nucleatum subsp. vincenti KCTC
5105, and Streptococcus mutans KCTC 3065. A. actino-
mycetemcomitans was cultivated on brucella medium (Sigma,
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Bactron IV chamber. C. albicans was cultivated on RPMI
1640 medium (Sigma, USA), F. nucleatum subsp. vincenti
was cultivated on Schaedler medium (Sigma, USA), and S.
mutans was cultivated on BHI medium (Sigma, USA) with
3% horse serum (Sigma, USA). All microorganism incuba-
tions were performed at 37°C.Figure 1 Purification of antimicrobial compounds isolated from EnteromDetermination of minimal inhibitory concentration (MIC)
values
The Determination of MIC values were performed as
described previously (Choi et al. 2012). Inocula were
prepared from 24-h broth cultures and then diluted to
ten volume of the original volume and adjusted to the
0.5 McFarland standard solution turbidity containingorpha linza. ↓: purification of stearidonic and gamma-linolenic acids.
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were prepared by dispensing the inoculum and active
compound into each well. The first well of each strip
contained 100 μL broth with no compound and 100 μL
inoculum, and represented the negative control. The
second well on each strip contained 90 μL broth, 10 μL
methanol, and 100 μL inoculum, and represented the
vechicle control. The final volume in each well was
200 μL. Following incubation, the MIC value was
defined as the lowest concentration that yielded no
bacterial cell growth (National Committee for Clinical
Laboratory Standards 2004). All MIC tests were
performed independently in triplicate. The antimicro-
bial agent’s triclosan-methyl (Sigma-Aldrich 34228) and
chlorhexidine (Sigma-Aldrich 282227) were included in
the assays as positive controls.
Quantification of the compound
To measure the levels of antimicrobial compounds in E.
linza, the thalli were completely dried in the shade at
room temperature for 1 week and ground into a powder
for 5 min. The powder (0.5 g) was extracted with 10 mL
dichloromethane on a rotator for 1 h at 30 rpm. Follow-
ing centrifugation at 2,000 × g for 5 min, 4 mL of the
clean supernatant was evaporated to 5 mg/mL for RP-
HPLC. Each 100-μL aliquot was separated on an Alltima
C18 column (10 mm ID × 25 cm) (W. R. Grace & Co.)
using the same isolation procedure. The compound levels
were assessed by measuring the dimensions of the HPLC
peaks using the standard curve of the pure compound.
Results
Isolation of antibacterial fractions
The purification procedure is shown in Figure 1. The
active compounds were obtained through methanol ex-
traction, chloroform fractionation, Sephadex fraction-
ation (S14), and HPLC fractionation (S14-2 and S14-3).
Fraction 14 from the Sephadex fractionation of theTable 1 Minimum inhibitory concentration (MIC) values and p
P. intermedia and P. gingivalis
Extract and fraction type P. intermedia
MIC (μg/mL) Purification fa
E. linza powder - -
Methanol extract 625* 1
Fraction III (chloroform fraction) 625 21
Sephadex fraction No. S14 78.12 24
HPLC fraction No. S14-1 156.25 23
HPLC fraction No. S14-2 (SA) 39.06 25
HPLC fraction No. S14-3 (GLA) 39.06 25
HPLC high-performance liquid chromatography, SA stearidonic acid, GLA gamma-lin
* The MIC values of methanol extract were adapted from Choi et al. (2012).
-: Not determined.chloroform fraction was found to be antibacterial against
both P. intermedia and P. gingivalis. Fraction S14 was
further fractionated by RP-HPLC. The active compounds
were eluted at 5.1 min (S14-1), 6.3 min (S14-2), and
7.9 min (S14-3), respectively, in isocratic 95% aceto-
nitrile by RP-HPLC. Among them, the antimicrobial
activities of S14-2 and S14-3 were much stronger than
those of S14-1. Thus, further isolation was conducted
using S14-2 and S14-3, which were oily and yellow.
The weights of S14-2 and S14-3 were 9.5 mg and
9.7 mg, and the yields were 6.33 × 10-3% and 6.47 × 10-3%,
respectively, from the dried seaweed powder. The antibac-
terial potency of the purified compounds was determined
by measuring MIC values. The MIC values of the extracts
and fractionates were measured against the anaerobic bac-
teria of P. intermedia and P. gingivalis (Table 1). The MIC
values of isolated S14-2 [stearidonic acid (SA)] and S14-3
[gamma-linolenic acid (GLA)] showing the same MIC
values were 39.06 μg/mL against P. intermedia and
9.76 μg/mL against P. gingivalis.
Identification of antibacterial compounds
Assignments were performed by analyzing heteronuclear
multiple-quantum correlation (HMQC), heteronuclear
multiple-bond correlation (HMBC), and correlation
spectroscopy (COSY) spectra. Infrared analysis of the
purified compounds showed absorption for OH and car-
bonyl function. The 1H-NMR data (Table 2) and 13C-
NMR spectra (Figure 2) of S14-2 (SA) and S14-3 (GLA)
were characteristic of an unsaturated fatty acid in its free
form. The GC–MS spectra (Figure 3) of S14-2 (methyl
ester) and S14-3 (methyl ester) were completely
superimposed over those of the commercial SA (methyl
ester) and γ-linolenic acid (methyl ester). From these spec-
tral data, we identified the compound as the polyunsatu-
rated fatty acids (PUFAs) 6,9,12,15-octadecatetraenoic acid
or SA (C18:4 n-3; Figure 4A) and 6,9,12-octadecatrienoic
acid or GLA (C18:3 n-6; Figure 4B).urification factor of the extract and fraction type against
P. gingivalis Yield (%)









Figure 2 13C nuclear magnetic resonance spectra of the antimicrobial fractions. 13C nuclear magnetic resonance spectra obtained in
methanol-d (CD3OD) at 500 MHz from the antimicrobial fractions (A) S14-2 (stearidonic acid) and (B) S14-3 (gamma-linolenic acid) from reverse-
phase, high-performance liquid chromatographic separation.
Table 2 1H nuclear magnetic resonance (NMR) data of the antimicrobial fractions: 1H NMR data obtained in methanol-d
(CD3OD) at 500 MHz from the antimicrobial fractions (a) S14–2 (stearidonic acid) and (b) S14–3 (gamma-linolenic acid)
from reverse-phase, high-performance liquid chromatographic separation
(a) (b)
1H Peak label on 1H-NMR spectrum 1H Peak label on 1H-NMR spectrum
C1 - - C1 - -
C2 2.27, t, 2H e C2 2.24–2.26, t, 2H e
C3 1.61, m, 2H c C3 1.57–1.60, m, 2H c
C4 1.41, m, 2H b C4 1.32, m, 2H b
C5 2.08–2.10, m, 2H d C5 2.04–2.09, m, 2H d
C6 5.34–5.36, m, 1H g C6 5.32–5.34, m, 1H g
C7 5.34–5.36, m, 1H g C7 5.32–5.34, m, 1H g
C8 2.81–2.83, m, 2H f C8 2.78–2.84, m, 2H f
C9 5.34–5.36, m, 1H g C9 5.32–5.34, m, 1H g
C10 5.34–5.36, m, 1H g C10 5.32–5.34, m, 1H g
C11 2.81–2.83, m, 2H f C11 2.78–2.84, m, 2H f
C12 5.34–5.36, m, 1H g C12 5.32–5.34, m, 1H g
C13 5.34–5.36, m, 1H g C13 5.32–5.34, m, 1H g
C14 2.81–2.83, m, 2H f C14 2.04–2.09, m, 2H d
C15 5.34–5.36, m, 1H g C15 1.32, m, 2H b
C16 5.34–5.36, m, 1H g C16 1.32, m, 2H b
C17 2.08–2.10, m, 2H d C17 1.32, m, 2H b
C18 0.97, t, 3H a C18 0.96, t, 3H a
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Figure 3 Gas chromatography–mass spectrometry spectra of antimicrobial fractions. (A) stearidonic acid, methyl ester (standard), (B) S14-2,
methyl ester (C) linolenic acid, methyl ester (standard), and (D) S14-3, methyl ester from reverse-phase, high-performance liquid chromatographic
separations that completely superimposed over those of commercial compounds.
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When the antimicrobial activities of the purified SA
(S14–2) and GLA (S14-3) and the commercially avail-
able SA (Sigma-Aldrich 49509) and GLA (Sigma-Aldrich
L2378) against P. intermedia and P. gingivalis were com-
pared, we observed no difference. The commerciallyFigure 4 Structures of purified compounds. (A) stearidonic acid
(C18:4 n-3) and (B) gamma-linolenic acid (C18:3 n-6).available SA and GLA were then tested for antimicrobial
activity against several oral pathogens, including A.
actinomycetemcomitans, C. albicans, F. nucleatum subsp.
vincenti, and S. mutans (Table 3). The MIC values of SA
were 312.50 μg/mL against A. actinomycetemcomitans,
312.50 μg/mL against C. albicans, 39.06 μg/mL against F.
nucleatum subsp. vincenti, and 1,250 μg/mL against S.
mutans. The MIC values of GLA were 78.12 μg/mL
against A. actinomycetemcomitans, 78.12 μg/mL against
C. albicans, 9.76 μg/mL against F. nucleatum subsp.
vincenti, and 625 μg/mL against S. mutans. Triclosan and
chlorhexidine, which are broad-spectrum antimicrobial
agents found in toothpaste, soap, deodorant, detergents,
cosmetics, pharmaceuticals, plastics, and fabrics (Nudera
et al. 2007; Haraszthy et al. 2006), were used as positive
controls. The MIC values of triclosan were not determined
against A. actinomycetemcomitans, 312.50 μg/mL against
C. albicans, 4.88 μg/mL against F. nucleatum subsp.
Table 3 Minimum inhibitory concentration (MIC) values of commercial stearidonic acid (SA) and gamma-linolenic acid
(GLA), and positive controls (triclosan and chlorhexidine) against several oral pathogens
Oral pathogens MIC value (μg/mL)
Positive controls SA GLA
Triclosan Chlorhexidine
Aggregatibacter actinomycetemcomitans ND 4.88 312.50 78.12
Candida albicans 312.50 4.88 312.50 78.12
Fusobacterium nucleatum subsp. vincenti 4.88 2.44 39.06 9.76
Streptococcus mutans ND 9.76 1,250 625
Prevotella intermedia 1,250 1.22 39.06 39.06
Porphyromonas gingivalis 78.12 1.22 9.76 9.76
All measurements were performed in triplicate, and are the average of three experiments; ND not determined.
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against P. intermedia, and 78.12 μg/mL against P. gingivalis.
The MIC values of chlorhexidine were 4.88 μg/mL against
A. actinomycetemcomitans, 4.88 μg/mL against C. albicans,
2.44 μg/mL against F. nucleatum subsp. vincenti, 9.76 μg/mL
against S. mutans, 1.22 μg/mL against P. intermedia, and
1.22 μg/mL against P. gingivalis. The MIC of triclosan was
23 μg/mL for P. intermedia and 6 μg/mL for P. gingivalis,
and the MICs of chlorhexidine were 67.5 μg/mL and
125 μg/mL, respectively. Extracts and volatile oil of E.
linza showed no activity against the yeast C. albicans
(Sukatar et al. 2006). Similarly, the methanol extracts of
E. compressa, E. muscoides, and Ulva rigida displayed
no activity against C. albicans (del Val et al. 2001).
Quantification of the compound
To quantify the active compounds directly from the sea-
weed tissue, 0.0131 g (2.62%) of dichloromethane extract
was obtained from 0.5 g of powder. The S14–2 and
S14–3 peaks were integrated using the Empower™ soft-
ware (Waters Co.), and the percentile dimensions were
measured as 18.87% and 5.22% by HPLC. The amounts
of S14–2 and S14–3 were calculated as 2.5 mg (0.50%)
and 0.7 mg (0.14%) from 0.5 g of E. linza powder.
Discussion
Periodontitis is a common chronic inflammatory disease
caused by the accumulation of a bacterial matrix at the
gum line (Socransky et al. 1999). It is characterized by
gum tissue separation from the tooth, which forms a
periodontal pocket that leads to bone and tooth loss.
Traditional antibiotic therapies for periodontitis target
the bacterial infection, which may be the initiating event
responsible for the ensuing inflammation and tissue de-
struction. However, antibiotics are known to induce side
effects (Falagas and Siakavellas 2000) and lead to the de-
velopment of bacterial resistance (Lopez and Gerwick
1988). In this study, we attempted to identify a new
therapeutic agent with few or no side effects and potent
antimicrobial activity from a seaweed source. Seaweed isabundant and produces diverse biologically active sub-
stances. In our previous screening, we found that green
seaweed (E. linza) extract displayed potent antimicrobial
activity against P. intermedia and P. gingivalis (Choi
et al. 2012). In this study, the active compounds were
identified as the unsaturated fatty acids SA (C18:4 n-3)
and GLA (C18:3 n-6) by GC–MS, 1H NMR, and 13C
NMR spectroscopy. SA and GLA were found to be ac-
tive against several oral pathogens.
Fatty acids of linolenic acid (Ohta et al. 1994),
palmitoleic acid and hexadecatrienoic acid (HTA)
(Desbois et al. 2008), and eicosapentaenoic acid (EPA)
(Desbois et al. 2009) were also identified as antimicrobial
agents against several human pathogens. SA isolated
from Undaria pinnatifida has been found to be active
against S. mutans (Yun et al. 2007). Several commercial
the ω-3 and ω-6 polyunsaturated fatty acids (PUFAs)
were also identified as antimicrobial agents against sto-
matitis, periodontitis and gingivitis (Choi et al. 2013).
Thus, free fatty acids may hold promise as a new topical
or systemic treatment for periodontitis.
PUFA toxicity has been attributed to its detergent ac-
tivity, which disrupts bacterial membranes and the
formation of short-chain aldehydic compounds by au-
tooxidation (Knapp and Melly 1986), and selectively
inhibits bacterial enoyl-acyl carrier reductase, an essential
component of bacterial fatty acid synthesis (Zheng et al.
2005). As a highly unsaturated (n-3) PUFA, the unsatu-
ration index of SA is lower than those of EPA and
docosahexaenoic acid (DHA); SA thus potentially dis-
plays improved stability characteristics, enhancing its
commercial value (Guil-Guerrero 2007; Whelan 2009).
GLA is produced in the body as an intermediate in the
metabolism of linoleic acid (LA), an essential fatty acid of
the omega-6 series, by the action of delta-6-
desaturase. GLA has gained importance due to its anti-
inflammatory and anti-cancer action, and has been
shown to improve nerve conduction velocity in patients
with diabetes, leading to improved blood flow and re-
duced tingling of the extremities (Kapoor and Huang
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rived from n-3 fatty acids has conferred dramatic protec-
tion against inflammation-induced tissue and bone loss
associated with periodontitis in experimental models
(Naqvi et al. 2010). Indeed, GLA displayed a protective
effect against periodontitis due to its anti-inflammatory
properties in randomized controlled human trials
(Rosenstein et al. 2003). In the case of SA, despite its
anti-inflammatory activity (Khan et al. 2007), its protect-
ive effect against periodontitis has not been confirmed.
The safety of SA was investigated in human studies of
SA-containing oils. When an SA intake ranging from 1
to 4 g/d was investigated in 28-d and 90-d rats, doses of
up to 4 g/kg body weight daily produced no SA-specific
adverse effect. Furthermore, SA-enriched soybean oil
has recently been obtained and is generally recognized
as safe (GRAS) for use as a food ingredient in the United
States (Lemke et al. 2010). As GLA is present in high
levels in maternal breast milk (Puri 2007), it would be
expected to be a safe product when used in moderation.Conclusions
In conclusion, we have shown for the first time that the
fatty acids SA and GLA inhibit the growth of oral patho-
gens. Moreover, mouth rinses containing the E. linza ex-
tract are effective against gingivitis disease (Cho et al.
2011), and the fatty acids of SA (Khan et al. 2007) and
GLA (Kapoor and Huang 2006) display anti-inflammatory
properties. To date, no bacterial resistance to free fatty
acids has been encountered and no resistance phenotype
has emerged (Desbois et al. 2009). Thus, this study pre-
sents a strategy for the prevention and/or treatment of
oral pathogen infection with minimal side effects and no
bacterial resistance.Competing interests
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